Associate Director, Compliance Field Commercialization, Lung
Revolution Medicines
Summary
The Associate Director, US Compliance, Field Commercialization, reporting to the Sr. Director, Compliance, will serve as a primary compliance business partner in support of the company's planned US commercialization activities for non-small cell lung cancer (NSCLC). The Associate Director is responsible for executing and managing the compliance strategy and program for NSCLC field organizations across Commercial and Medical.
Job description
Essential Duties and Responsibilities
- Serve as a compliance business partner for field organizations, including Sales, Marketing, Medical Affairs, Patient Services, and other functions.
- Provide strategic and actionable compliance guidance regarding field execution, emerging risks, and business initiatives.
- Lead the identification, assessment, and mitigation of compliance risks associated with field activities and commercialization efforts.
- Develop and implement scalable compliance solutions that support evolving business needs and product launches.
- Execute on the strategy, design, and governance of field compliance training programs across field-facing NSCLC teams.
- Develop risk-based training plans informed by business activities, monitoring insights, audit findings, industry trends, enforcement actions, and regulatory developments.
- Serve as a presenter and facilitator for compliance training at national sales meetings, launch meetings, leadership forums, and onboarding programs.
- Evaluate training effectiveness through metrics, feedback, and monitoring results and implement continuous improvements.
- Assist with the development, implementation, and governance of policies, SOPs, standards, and guidance impacting field-facing NSCLC activities.
- Ensure compliance policies and procedures remain current with evolving regulatory requirements, industry standards, and business needs.
- Drive cross-functional governance initiatives and facilitate alignment among Compliance, Legal, and business stakeholders.
- Establish practical frameworks, job aids, and guidance documents that enable consistent and compliant field execution.
- Execute field-related monitoring activities with the broader Compliance team.
- Analyze monitoring trends and audit results to identify systemic risks, root causes, and opportunities for process improvement.
- Develop and oversee corrective and preventive action plans (CAPAs) related to field compliance observations.
- Regularly communicate compliance risk assessments, trends, and recommendations to Compliance leadership and key business stakeholders.
- Maintain expert-level knowledge of healthcare laws, regulations, and industry guidance affecting Commercial and Medical Affairs field activities, including OIG guidelines, US Sunshine requirements, FDA promotional regulations, state compliance requirements, data privacy laws, and the PhRMA Code.
- Monitor industry trends, enforcement actions, and best practices to proactively assess potential impact on Revolution Medicines.
- Represent Compliance on cross-functional governance committees, launch teams, and strategic business initiatives.
- Contribute to the evolution of the company's compliance program through external benchmarking and industry engagement.
Required Skills, Experience and Education
- Bachelor's degree required; advanced degree preferred.
- 6+ years of healthcare compliance experience in pharmaceuticals or biotechnology; in-house compliance experience strongly preferred.
- Experience as a compliance business partner with familiarity with the compliance risks associated with relevant business activities.
- Demonstrated ability to build strong partnerships and collaborate with internal business partners, including field-facing roles.
- Demonstrated ability to influence leaders and serve as a trusted advisor on compliance matters.
- Strong presentation, organizational, and project management skills, capable of handling multiple high-priority projects simultaneously.
- Team-oriented approach to work, and ability to lead through influence in a dynamic environment.
- Excellent communication, analytical, and problem-solving skills, with the ability to work collaboratively with legal, scientific, and business functions.
- Ability to travel as required (approximately 25-50%).
Preferred Skills
- Experience supporting pre-commercial pharma or biotech companies through launch planning and commercial product launch.
- Certified Compliance & Ethics Professional (CCEP) certification.
- Oncology and/or specialty pharmaceutical experience.
Requirements
- Bachelor's degree required; advanced degree preferred.
- 6+ years of healthcare compliance experience in pharmaceuticals or biotechnology; in-house compliance experience strongly preferred.
- Experience as a compliance business partner with familiarity with the compliance risks associated with relevant business activities.
- Demonstrated ability to build strong partnerships and collaborate with internal business partners, including field-facing roles.
- Demonstrated ability to influence leaders and serve as a trusted advisor on compliance matters.
- Strong presentation, organizational, and project management skills, capable of handling multiple high-priority projects simultaneously.
- Team-oriented approach to work, and ability to lead through influence in a dynamic environment.
- Excellent communication, analytical, and problem-solving skills, with the ability to work collaboratively with legal, scientific, and business functions.
- Ability to travel as required (approximately 25-50%).
- Experience supporting pre-commercial pharma or biotech companies through launch planning and commercial product launch.
- Certified Compliance & Ethics Professional (CCEP) certification.
- Oncology and/or specialty pharmaceutical experience.
Benefits
- Competitive cash compensation
- Equity awards
- Health benefits
- Learning and development opportunities
Company overview
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The company is pioneering a new class of therapeutics that target oncogenic RAS mutations, which are among the most common drivers of human cancers. Revolution Medicines employs a unique approach to drug discovery, leveraging deep insights into RAS biology to develop small molecule inhibitors that can address previously undruggable targets. Their pipeline includes multiple clinical-stage candidates designed to inhibit various RAS pathway mutations, with a particular focus on KRAS G12C and other RAS variants. The company's scientific platform combines structural biology, medicinal chemistry, and computational approaches to design highly selective inhibitors. Revolution Medicines aims to transform cancer treatment by developing therapies that can overcome resistance mechanisms and provide durable clinical benefits for patients with RAS-driven malignancies. Their research represents a significant advancement in the field of targeted cancer therapy, addressing one of the most challenging areas in oncology drug development.